BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38824577)

  • 1. TORSEL, a 4EBP1-based mTORC1 live-cell sensor, reveals nutrient-sensing targeting by histone deacetylase inhibitors.
    Li C; Yi Y; Ouyang Y; Chen F; Lu C; Peng S; Wang Y; Chen X; Yan X; Xu H; Li S; Feng L; Xie X
    Cell Biosci; 2024 Jun; 14(1):68. PubMed ID: 38824577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquilin-mediated Small Molecule Inhibition of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling.
    Coffey RT; Shi Y; Long MJ; Marr MT; Hedstrom L
    J Biol Chem; 2016 Mar; 291(10):5221-33. PubMed ID: 26740621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2.
    Gupta M; Ansell SM; Novak AJ; Kumar S; Kaufmann SH; Witzig TE
    Blood; 2009 Oct; 114(14):2926-35. PubMed ID: 19641186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Multifaceted Role of Nutrient Sensing and mTORC1 Signaling in Physiology and Aging.
    Fernandes SA; Demetriades C
    Front Aging; 2021; 2():707372. PubMed ID: 35822019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms.
    Wilson-Edell KA; Yevtushenko MA; Rothschild DE; Rogers AN; Benz CC
    Breast Cancer Res Treat; 2014 Apr; 144(2):287-298. PubMed ID: 24562770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent HDAC and mTORC1 inhibition attenuate androgen receptor and hypoxia signaling associated with alterations in microRNA expression.
    Ellis L; Lehet K; Ramakrishnan S; Adelaiye R; Miles KM; Wang D; Liu S; Atadja P; Carducci MA; Pili R
    PLoS One; 2011; 6(11):e27178. PubMed ID: 22087262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras proto-oncogenes in mice.
    Wang C; Cigliano A; Jiang L; Li X; Fan B; Pilo MG; Liu Y; Gui B; Sini M; Smith JW; Dombrowski F; Calvisi DF; Evert M; Chen X
    Hepatology; 2015 Jan; 61(1):200-13. PubMed ID: 25145583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MNK1 pathway activity maintains protein synthesis in rapalog-treated gliomas.
    Grzmil M; Huber RM; Hess D; Frank S; Hynx D; Moncayo G; Klein D; Merlo A; Hemmings BA
    J Clin Invest; 2014 Feb; 124(2):742-54. PubMed ID: 24401275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling.
    Balgi AD; Fonseca BD; Donohue E; Tsang TC; Lajoie P; Proud CG; Nabi IR; Roberge M
    PLoS One; 2009 Sep; 4(9):e7124. PubMed ID: 19771169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition.
    Ito H; Ichiyanagi O; Naito S; Bilim VN; Tomita Y; Kato T; Nagaoka A; Tsuchiya N
    BMC Cancer; 2016 Jul; 16():393. PubMed ID: 27387559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapy for mTORC1-driven tumours through HDAC inhibition by exploiting innate vulnerability of mTORC1 hyper-activation.
    Yang F; Sun S; Wang C; Haas M; Yeo S; Guan JL
    Br J Cancer; 2020 Jun; 122(12):1791-1802. PubMed ID: 32336756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased milk protein synthesis in response to exogenous growth hormone is associated with changes in mechanistic (mammalian) target of rapamycin (mTOR)C1-dependent and independent cell signaling.
    Sciascia Q; Pacheco D; McCoard SA
    J Dairy Sci; 2013 Apr; 96(4):2327-2338. PubMed ID: 23462168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic Target of Rapamycin Complex 1: From a Nutrient Sensor to a Key Regulator of Metabolism and Health.
    Wang G; Chen L; Qin S; Zhang T; Yao J; Yi Y; Deng L
    Adv Nutr; 2022 Oct; 13(5):1882-1900. PubMed ID: 35561748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular accumulation of tau inhibits autophagosome formation by activating TIA1-amino acid-mTORC1 signaling.
    Li MZ; Liu EJ; Zhou QZ; Li SH; Liu SJ; Yu HT; Pan QH; Sun F; He T; Wang WJ; Ke D; Feng YQ; Li J; Wang JZ
    Mil Med Res; 2022 Jul; 9(1):38. PubMed ID: 35799293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamin-dependent amino acid endocytosis activates mechanistic target of rapamycin complex 1 (mTORC1).
    Shibutani S; Okazaki H; Iwata H
    J Biol Chem; 2017 Nov; 292(44):18052-18061. PubMed ID: 28808055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RING-type E3 ligase RNF186 ubiquitinates Sestrin-2 and thereby controls nutrient sensing.
    Lear TB; Lockwood KC; Ouyang Y; Evankovich JW; Larsen MB; Lin B; Liu Y; Chen BB
    J Biol Chem; 2019 Nov; 294(45):16527-16534. PubMed ID: 31586034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of mTORC1 signaling in placental nutrient-sensing.
    Jansson T; Aye IL; Goberdhan DC
    Placenta; 2012 Nov; 33 Suppl 2(Suppl 2):e23-9. PubMed ID: 22687819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo.
    Shao H; Gao C; Tang H; Zhang H; Roberts LR; Hylander BL; Repasky EA; Ma WW; Qiu J; Adjei AA; Dy GK; Yu C
    J Hepatol; 2012 Jan; 56(1):176-83. PubMed ID: 21835141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relieving autophagy and 4EBP1 from rapamycin resistance.
    Nyfeler B; Bergman P; Triantafellow E; Wilson CJ; Zhu Y; Radetich B; Finan PM; Klionsky DJ; Murphy LO
    Mol Cell Biol; 2011 Jul; 31(14):2867-76. PubMed ID: 21576371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamine deficiency drives transforming growth factor-β signaling activation that gives rise to myofibroblastic carcinoma-associated fibroblasts.
    Mezawa Y; Wang T; Daigo Y; Takano A; Miyagi Y; Yokose T; Yamashita T; Yang L; Maruyama R; Seimiya H; Orimo A
    Cancer Sci; 2023 Nov; 114(11):4376-4387. PubMed ID: 37706357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.